Structures by: Cobo J.


Structures by: Cobo J.

Results: 489


#NameUnit Cell
20043375-Dimethylamino-2-methoxy-3-methyl-6-[1,2-(Z)-dicarbomethoxyvinyl]amino pyrimidin-4-(3H)-one
Acta Crystallographica Section C (1996) 52, 1 254-256
a=8.7777(7)
b=16.8264(18)
c=11.3773(9)
α= 90.00
β= 93.077(7)
γ= 90.00
V = 1678.0(3)
20043402-methylthio-5-nitroso-6-N-(2,3,4-tri-O-acetyl-β-D-xylopyranosyl)amino- pyrimidin-4-(3H)-one
Acta Crystallographica Section C (1996) 52, 1 148-150
a=6.9874(4)
b=10.647(2)
c=27.0341(16)
α= 90.00
β= 90.00
γ= 90.00
V = 2011.2(4)
20074755-Bis(trimethylsilyl)amino-2-methoxy-3-methyl-6-(trimethylsilylamino)- pyrimidin-4(3H)-one
Acta Crystallographica Section C (1998) 54, 7 IUC9800030
a=10.2091(9)
b=11.4381(9)
c=20.236(3)
α= 90.00
β= 93.831(9)
γ= 90.00
V = 2357.7(4)
20085155,5,6-Triacetyl-5,6-diaminopyrimidine-2,4-(1H,3H)-dione
Acta Crystallographica Section C (1999) 55, 5 749-751
a=22.2132(15)
b=12.9986(13)
c=8.5456(5)
α= 90.00
β= 96.107(5)
γ= 90.00
V = 2453.5(3)
20093142,4-Dioxo-7-(D-arabino-1,2,3,4-tetraacetyloxibutyl)-1-methyl- 1,2,3,4-tetrahydropteridine
Acta Crystallographica Section C (1999) 55, 12 IUC9900163
a=7.7633(8)
b=22.049(2)
c=13.0223(19)
α= 90.00
β= 90.00
γ= 90.00
V = 2229.1(4)
20093156-Amino-5-N-acetyl-N-(β-D-3,4,6-tri-O-acetylglucopyranosyl)amino- 2,4-dioxo-1,2,3,4-tetrahydro-3-methylpyrimidine, water solvent
Acta Crystallographica Section C (1999) 55, 12 IUC9900164
a=14.3951(11)
b=8.9771(9)
c=19.052(2)
α= 90.00
β= 90.00
γ= 90.00
V = 2462.0(4)
20093166-Acetamido-5-N-acetyl-N-(β-D-2,3,4,6-tetra-O-acetylglucopyranosyl)amino- 2,4-dioxo-1,2,3,4-tetrahydro-3-methyl-pyrimidine
Acta Crystallographica Section C (1999) 55, 12 IUC9900164
a=9.0315(8)
b=17.0918(13)
c=18.1487(13)
α= 90.00
β= 90.00
γ= 90.00
V = 2801.5(4)
20093314-(4-chlorophenyl)-5-cyano-3-(4-methylphenyl)-6-diphenyl-4,7-dihydro-2H-pyrazolo [3,4-b]pyridine:dimethylformamide (2/1)
Acta Crystallographica Section C (1999) 55, 12 IUC9900168
a=12.4124(5)
b=13.8275(4)
c=14.3744(6)
α= 91.747(2)
β= 106.6376(17)
γ= 99.610(2)
V = 2322.64(15)
20096176-amino-2-methoxy-3-methyl-5-[(E)-1,2-dicarbomethoxyvinyl]pyrimidin-4-(3H)- one
Acta Crystallographica Section C (1994) 50, 4 585-587
a=7.4731(7)
b=10.8843(8)
c=9.0286(6)
α= 90.0
β= 112.992(7)
γ= 90.0
V = 676.04(10)
2011544Methyl 2-methyl-6-methylthio-1,3-dioxo-4-[(2,3,4,6-tetra-O-acetyl-β-D- glucopyranosyl)amino]-2,3-dihydro-1H-pyrrolo[3,4-c]pyridine-7-carboxylate
Acta Crystallographica Section C (2000) 56, 11 e526-e527
a=10.1696(9)
b=6.9695(7)
c=21.526(2)
α= 90.00
β= 92.036(5)
γ= 90.00
V = 1524.7(2)
20116152,4-bis(2-hydroxybenzoyl)-2,3-dihydro-1H-pyrido[2,1-b][1,3]benzothiazole
Acta Crystallographica Section C (2000) 56, 12 1460-1461
a=7.4978(15)
b=11.265(2)
c=12.322(3)
α= 108.12(3)
β= 99.38(3)
γ= 94.75(3)
V = 966.0(4)
20116165,5-dimethyl-3-(5-methyl-1H-pyrazol-3-ylamino)cyclohex-3-en-1-one
Acta Crystallographica Section C (2000) 56, 12 1457-1459
a=12.5130(3)
b=9.4275(3)
c=10.6441(3)
α= 90.00
β= 90.00
γ= 90.00
V = 1255.65(6)
2011985Aqua-[N-(6-amino-3,4-dihydro-3-methyl-5-nitroso-4-oxopyrimidin-2-yl)glycyl- glycinato]potassium
Acta Crystallographica Section C (2001) 57, 5 534-537
a=7.4440(4)
b=7.4642(4)
c=13.5136(6)
α= 80.3701(17)
β= 76.0568(18)
γ= 68.6413(14)
V = 676.06(6)
2012032Triaqua-bis[N-(6-amino-3,4-dihydro-3-methyl-5-nitroso-4-oxopyrimidin-2- yl)glycylglycinato]calcium
Acta Crystallographica Section C (2001) 57, 6 680-682
a=12.7815(7)
b=7.7010(7)
c=26.271(2)
α= 90
β= 96.418(5)
γ= 90
V = 2569.7(3)
20123274-(4-Chlorophenyl)-3,7,7-trimethyl-1-[2-(4-nitrobenzoyl)ethyl]-4,7,8,9- tetrahydro-1H-pyrazolo[3,4-b]quinolin-5(6H)-one-ethanol (1/1)
Acta Crystallographica Section C (2001) 57, 11 1356-1358
a=23.6298(6)
b=9.6215(3)
c=14.2657(4)
α= 90
β= 120.2930(16)
γ= 90
V = 2800.51(14)
20124625-(3-(4-chlorophenyl)-2-propenylidene]-2,2-dimethyl-[1,3] dioxane-4,6-dione
Acta Crystallographica Section C (2002) 58, 1 o39-o41
a=7.2648(2)
b=7.4705(3)
c=13.5855(6)
α= 90.1799(13)
β= 99.8452(14)
γ= 109.576(3)
V = 683.01(5)
20125014-(4-Methylphenyl)-3,4-dihydropyrimido[1,2-a]benzimidazol-2(1H)-one
Acta Crystallographica Section C (2002) 58, 2 o125-o128
a=8.1360(3)
b=9.8647(4)
c=10.0975(5)
α= 114.8796(13)
β= 94.9156(15)
γ= 100.966(3)
V = 709.18(5)
20125233-methyl-1,5-diphenyl-1,6,7,8-tetrahydropyrazolo[3,4-b][1,4]diazepine
Acta Crystallographica Section C (2002) 58, 2 o103-o105
a=30.5212(7)
b=30.5212(7)
c=8.8689(2)
α= 90.00
β= 90.00
γ= 120.00
V = 7154.9(3)
20125245-(4-Chlorophenyl)-3-methyl-1-phenyl-1,6,7,8- tetrahydropyrazolo[3,4-b][1,4]diazepine
Acta Crystallographica Section C (2002) 58, 2 o103-o105
a=9.0066(18)
b=17.969(4)
c=18.007(4)
α= 115.73(3)
β= 101.02(3)
γ= 98.83(3)
V = 2483.0(13)
20127065-(4-Bromophenyl)-2-(4-chlorophenyl)-1,5,6,10b-tetrahydropyrazolo[1,5-c] quinazoline
Acta Crystallographica Section C (2002) 58, 5 o305-o310
a=5.55600(10)
b=12.2526(2)
c=14.0827(3)
α= 77.9230(9)
β= 83.0060(8)
γ= 87.8140(10)
V = 930.41(3)
20136632,2-Methylenebis(3-hydroxy-5,5-dimethylcyclohex-2-en-1-one)
Acta Crystallographica Section C (2003) 59, 12 o666-o668
a=18.8968(4)
b=18.8989(4)
c=8.7038(2)
α= 90.00
β= 90.00
γ= 90.00
V = 3108.38(12)
20138745-(4-Chlorophenyl)-2-methoxyindeno[1,2:2,3]pyrido[5,6-d]pyrimidine- 4,6(3H,5H)-dione—–dimethylformamide (1/1)
Acta Crystallographica Section C (2004) 60, 3 o186-o190
a=10.6850(6)
b=17.6182(12)
c=12.3774(8)
α= 90.00
β= 108.523(4)
γ= 90.00
V = 2209.3(2)
2013875(5RS,5aSR,10bSR)-10b-hydroxy-2-methoxy-5-(4-methoxyphenyl)-5a-10b- dihydroindeno[1,2:2,3]pyrido[5,6-d]pyrimidine-4,6(3H,5H)-dione—– dimethylformamide (1/1)
Acta Crystallographica Section C (2004) 60, 3 o186-o190
a=10.4172(2)
b=10.8540(3)
c=11.6112(3)
α= 94.2692(12)
β= 116.0676(12)
γ= 94.4530(13)
V = 1167.08(5)
20140728-Hydroxymethyl-4,4-dimethyl-2-methylsulfanyl-3,4,5,6,7,8- hexahydropyrido[2,3-d]pyrimidine-6-spiro-1-cyclohexane-2,4,6-trione
Acta Crystallographica Section C (2004) 60, 6 o438-o443
a=6.6682(2)
b=11.0319(3)
c=12.3449(4)
α= 109.2678(18)
β= 99.8329(18)
γ= 101.227(2)
V = 813.32(5)
20143895-Chloro-3-methyl-4-[3-(4-nitrophenyl)-4,5-dihydro-1H-pyrazol-5-yl]-1-phenyl- 1H-pyrazole
Acta Crystallographica Section C (2006) 62, 1 o30-o32
a=5.5055(2)
b=11.8317(3)
c=13.5668(4)
α= 83.3210(17)
β= 78.9560(17)
γ= 86.3960(18)
V = 860.73(5)
20150532-(4-bromophenyl)-5-methyl-7,8-dihydro-6H- cyclopenta[g]pyrazolo[1,5-a]pyrimidine
Acta Crystallographica Section C (2005) 61, 7 o452-o456
a=13.5387(6)
b=6.8551(2)
c=15.2767(7)
α= 90.00
β= 105.708(2)
γ= 90.00
V = 1364.87(10)
2015312N-(2-Methoxy-6-oxopyrimidin-4-yl)formamide
Acta Crystallographica Section C (2006) 62, 5 o256-o258
a=7.0515(7)
b=9.0031(12)
c=11.237(2)
α= 90.00
β= 93.690(11)
γ= 90.00
V = 711.91(17)
20155223,7-diamino-2,5-dimethylpyrazolo[1,5-a]pyrimidine monohydrate
Acta Crystallographica Section C (2006) 62, 8 o521-o524
a=8.0970(2)
b=9.8881(3)
c=11.9661(3)
α= 90.00
β= 96.230(5)
γ= 90.00
V = 952.40(5)
2015579(E)-3-(4-bromophenyl)-2-(2-thienyl)acrylonitrile
Acta Crystallographica Section C (2006) 62, 9 o550-o553
a=3.8557(2)
b=24.0484(7)
c=12.5466(4)
α= 90.00
β= 96.877(2)
γ= 90.00
V = 1154.99(8)
20163822-ethylsulfanyl-7-(4-methylphenyl)-4-phenylpyrazolo[1,5-a][1,3,5]triazine
Acta Crystallographica Section C (2008) 64, 1 o27-o30
a=4.8076(3)
b=11.6397(5)
c=15.5010(7)
α= 92.164(4)
β= 96.217(5)
γ= 100.087(4)
V = 847.56(8)
2016763(2SR,4RS)-7-Fluoro-2-exo-(2-furyl)-2,3,4,5-tetrahydro-1H-1,4-epoxy- 1-benzazepine
Acta Crystallographica Section C (2008) 64, 9 o524-o528
a=5.5314(10)
b=15.430(4)
c=26.229(6)
α= 90.00
β= 92.960(17)
γ= 90.00
V = 2235.6(9)
2016764(2SR,4RS)-2-exo-(5-bromo-2-thienyl)-7-fluoro- 2,3,4,5-tetrahydro-1H-1,4-epoxy-1-benzazepine
Acta Crystallographica Section C (2008) 64, 9 o524-o528
a=8.1835(6)
b=10.9447(8)
c=14.6940(12)
α= 90.00
β= 104.969(6)
γ= 90.00
V = 1271.42(17)
2016766Hexamethylenediammonium bis(chloroacetate)
Acta Crystallographica Section C (2008) 64, 9 o505-o507
a=6.5779(18)
b=7.3593(10)
c=8.425(2)
α= 97.277(12)
β= 95.631(15)
γ= 111.037(12)
V = 373.03(15)
2016770(2SR,4RS)-7-chloro-2-exo-(4-chlorophenyl)-2,3,4,5-tetrahydro- 1H-1,4-epoxy-1-benzazepine
Acta Crystallographica Section C (2008) 64, 9 o519-o523
a=11.9348(11)
b=21.617(2)
c=5.3024(6)
α= 90.00
β= 90.00
γ= 90.00
V = 1368.0(2)
2016815(1RS,2SR,3RS,5SR)-2-Benzoyl-4,4-dicyano-1,3,5-triphenylcyclohexanol
Acta Crystallographica Section C (2008) 64, 10 o578-o582
a=10.9251(18)
b=11.777(3)
c=11.9438(12)
α= 90.417(13)
β= 112.616(9)
γ= 112.750(14)
V = 1286.1(5)
20168603-tert-Butyl-7-(4-chlorobenzyl)-4,4-dimethyl-1-phenyl-4,5,6,7- tetrahydro-1H-pyrazolo[3,4-b]pyridine-5-spiro-1-cyclohexane- 2,6-dione ethanol hemisolvate
Acta Crystallographica Section C (2008) 64, 12 o637-o642
a=27.419(4)
b=10.5860(13)
c=21.580(3)
α= 90.00
β= 122.625(11)
γ= 90.00
V = 5275.4(14)
20168613-tert-Butyl-7-(4-bromobenzyl)-4,4-dimethyl-1-phenyl-4,5,6,7- tetrahydro-1H-pyrazolo[3,4-b]pyridine-5-spiro-1-cyclohexane- 2,6-dione ethanol hemisolvate
Acta Crystallographica Section C (2008) 64, 12 o637-o642
a=27.4453(7)
b=10.5519(8)
c=21.715(2)
α= 90.00
β= 122.484(7)
γ= 90.00
V = 5304.7(8)
20168623-tert-Butyl-4,4-dimethyl-7-(4-methylbenzyl)-1-phenyl-4,5,6,7- tetrahydro-1H-pyrazolo[3,4-b]pyridine-5-spiro-1-cyclohexane- 2,6-dione ethanol hemisolvate
Acta Crystallographica Section C (2008) 64, 12 o637-o642
a=27.281(5)
b=10.6438(15)
c=21.567(3)
α= 90.00
β= 122.082(12)
γ= 90.00
V = 5306.1(16)
20168633-tert-Butyl-4,4-dimethyl-1-phenyl-7-[4-(trifluoromethyl)benzyl]- 4,5,6,7-tetrahydro-1H-pyrazolo[3,4-b]pyridine-5-spiro-1- cyclohexane-2,6-dione ethanol hemisolvate
Acta Crystallographica Section C (2008) 64, 12 o637-o642
a=10.3270(12)
b=11.9970(14)
c=12.427(3)
α= 75.016(13)
β= 70.059(11)
γ= 84.481(9)
V = 1398.0(4)
20168772-Amino-4-methoxy-6-(2-fluorophenyl)-11H-pyrimido[4,5- b][1,4]benzodiazepine
Acta Crystallographica Section C (2008) 64, 12 o643-o648
a=6.9115(10)
b=12.8801(14)
c=16.560(2)
α= 90.00
β= 95.110(10)
γ= 90.00
V = 1468.3(3)
20168782-Amino-4-methoxy-6-(3-nitrophenyl)-11H-pyrimido[4,5- b][1,4]benzodiazepine
Acta Crystallographica Section C (2008) 64, 12 o643-o648
a=7.047(4)
b=13.502(7)
c=16.418(5)
α= 90.00
β= 91.22(5)
γ= 90.00
V = 1561.8(13)
20168833-tert-butyl-4,4-dimethyl-1-phenyl-7-(3,4,5-trimethoxybenzyl)- 4,5,6,7-tetrahydro-1H-pyrazolo[3,4-b]pyridine-5-spiro-1- cyclohexane-2,6-dione ethanol 0.67-solvate
Acta Crystallographica Section C (2008) 64, 12 o665-o670
a=13.5770(17)
b=17.476(3)
c=26.670(3)
α= 90.00
β= 90.00
γ= 90.00
V = 6328.0(15)
20170104-Hydroxy-2-vinyl-2,3,4,5-tetrahydro-1-benzazepine
Acta Crystallographica Section C (2009) 65, 3 o92-o96
a=10.3466(13)
b=7.488(3)
c=13.227(9)
α= 90.00
β= 92.94(2)
γ= 90.00
V = 1023.4(8)
20170117-fluoro-4-hydroxy-2-vinyl-2,3,4,5-tetrahydro-1-benzazepine
Acta Crystallographica Section C (2009) 65, 3 o92-o96
a=10.5258(13)
b=7.4501(13)
c=13.251(2)
α= 90.00
β= 93.441(2)
γ= 90.00
V = 1037.2(3)
20170127-chloro-4-hydroxy-2-vinyl-2,3,4,5-tetrahydro-1-benzazepine
Acta Crystallographica Section C (2009) 65, 3 o92-o96
a=11.0850(7)
b=7.4214(10)
c=13.4588(11)
α= 90.00
β= 94.721(8)
γ= 90.00
V = 1103.45(19)
20170202-amino-6-anilino-4-methoxy-5-[(E)-4-nitrobenzylideneamino]pyrimidine dimethyl sulfoxide solvate
Acta Crystallographica Section C (2009) 65, 3 o111-o114
a=8.0386(8)
b=10.6862(14)
c=12.8856(13)
α= 71.007(11)
β= 74.463(9)
γ= 88.672(12)
V = 1005.9(2)
20170212-amino-6-[methyl(phenyl)amino]-5-[(E)-4-nitrobenzylideneamino]pyrimidin- 4(3H)-one dimethyl sulfoxide solvate
Acta Crystallographica Section C (2009) 65, 3 o111-o114
a=10.2601(8)
b=10.4555(6)
c=11.4537(14)
α= 113.230(7)
β= 112.295(8)
γ= 96.709(8)
V = 992.0(2)
2017062(2RS,4SR)-7-bromo-2-(4-chlorophenyl-2,3,4,5-tetrahydro- 1,4-epoxynaphtho[1,2-b]azepine
Acta Crystallographica Section C (2009) 65, 4 o140-o145
a=9.7758(16)
b=9.8211(14)
c=33.174(3)
α= 90.000
β= 90.000
γ= 90.000
V = 3185.0(7)
2017063(2RS,4SR)-2-(4-fluorophenyl)-2,3,4,5-tetrahydro-1,4- epoxynaphtho[1,2-b]azepine
Acta Crystallographica Section C (2009) 65, 4 o140-o145
a=11.3036(4)
b=12.7585(5)
c=11.1730(3)
α= 90.00
β= 109.137(2)
γ= 90.00
V = 1522.29(9)
20170983-{[4-Amino-6-methoxy-2-(methylsulfanyl)pyrimidin-5-yl]amino}-1,2- biindenylidene-1,3-dione dimethyl sulfoxide solvate
Acta Crystallographica Section C (2009) 65, 5 o229-o232
a=10.6056(5)
b=10.9946(11)
c=12.6770(11)
α= 69.780(13)
β= 76.523(5)
γ= 64.484(7)
V = 1245.6(2)
2017099Piperidinium 6-amino-3-methyl-5-nitroso-2,4-dioxo-1,2,3,tetrahydropyrimidin-1-ide 6-amino-3-methyl-5-nitrosopyrimidine-2,4(1H,3H)-dione
Acta Crystallographica Section C (2009) 65, 5 o257-o260
a=9.3287(19)
b=13.1352(10)
c=16.2814(19)
α= 87.815(10)
β= 74.095(10)
γ= 89.987(16)
V = 1917.2(5)
2017137N^4^-Methyl-N^4^-(2-methylphenyl)-1H-pyrazolo[3,4- d]pyrimidine-4,6-diamine—–ethanol—–hydrazine (1/0.865/0.135)
Acta Crystallographica Section C (2009) 65, 6 o293-o295
a=16.349(3)
b=14.051(2)
c=13.625(3)
α= 90.00
β= 99.308(18)
γ= 90.00
V = 3088.7(10)
20171483-Methyl-7-(2-thienyl)pyrido[2,3-d]pyrimidine-2,4(1H,3H)- dione
Acta Crystallographica Section C (2009) 65, 6 o284-o286
a=12.1969(15)
b=13.4010(13)
c=6.6071(8)
α= 90.00
β= 92.134(11)
γ= 90.00
V = 1079.2(2)
2017149catena-Poly[[[aquachloridocopper(II)]-μ-N-(6-amino-3-methyl- 5-nitroso-4-oxo-3,4-dihydropyrimidin-2-yl)glycinato] monohydrate]
Acta Crystallographica Section C (2009) 65, 6 m231-m234
a=6.9807(5)
b=9.1462(6)
c=11.2512(6)
α= 107.357(5)
β= 105.037(5)
γ= 102.028(6)
V = 629.54(8)
20171553-tert-butyl-5-(4-nitrobenzylamino)-1-phenyl-1H-pyrazole
Acta Crystallographica Section C (2009) 65, 6 o303-o310
a=9.6594(11)
b=12.3991(11)
c=15.4338(15)
α= 90.00
β= 97.744(8)
γ= 90.00
V = 1831.6(3)
20171563-tert-butyl-5-(3,4,5-trimethoxybenzylamino)-1-phenyl-1H-pyrazole
Acta Crystallographica Section C (2009) 65, 6 o303-o310
a=10.1533(11)
b=11.1645(10)
c=20.927(2)
α= 84.820(8)
β= 82.988(8)
γ= 63.153(7)
V = 2099.0(4)
20171842-Methoxy-3-methyl-6-oxo-4-(2,3,4-tri-O-acetyl-β-D-xylopyranosylamino)- 1,6-dihydropyrimidine-5-carbaldehyde 0.065-hydrate
Acta Crystallographica Section C (2009) 65, 7 o321-o325
a=14.3816(2)
b=14.7626(2)
c=20.1025(3)
α= 90.00
β= 90.00
γ= 90.00
V = 4267.96(10)
20171851,6-dihydropyrimidine-5-carbaldehyde
Acta Crystallographica Section C (2009) 65, 7 o321-o325
a=6.92940(10)
b=10.7415(2)
c=26.4825(5)
α= 90.00
β= 90.00
γ= 90.00
V = 1971.15(6)
20171996-(3,4,5-trimethoxyphenyl)-6,7-dihydro- 5H-1,3-dioxolo[4,5-g]quinolin-8(5H)-one
Acta Crystallographica Section C (2009) 65, 7 o326-o330
a=27.0927(8)
b=9.6631(4)
c=14.4579(6)
α= 90.00
β= 117.925(2)
γ= 90.00
V = 3344.3(2)
20172006-(1,3-benzodioxol-5-yl)-6,7-dihydro-5H-1,3- dioxolo[4,5-g]quinolin-8-one
Acta Crystallographica Section C (2009) 65, 7 o326-o330
a=12.9403(4)
b=7.1310(2)
c=14.7736(7)
α= 90.00
β= 103.7580(13)
γ= 90.00
V = 1324.15(8)
20172233-tert-butyl-7-(4-nitrobenzyl)-1-phenyl-6,7-dihydro- 1H,4H-pyrazolo[3,4-d][1,3]oxazine
Acta Crystallographica Section C (2009) 65, 8 o423-o430
a=19.164(2)
b=8.7781(7)
c=11.7188(12)
α= 90.00
β= 101.717(10)
γ= 90.00
V = 1930.3(3)
2017278(2SR,4RS)-7-chloro-2-exo-(2-chloro-6-fluorophenyl)- 2,3,4,5-tetrahydro-1H-1,4-epoxy-1-benzazepine
Acta Crystallographica Section C (2009) 65, 9 o465-o469
a=9.2907(11)
b=10.8720(9)
c=13.4523(13)
α= 90.00
β= 95.964(8)
γ= 90.00
V = 1351.4(2)
2017279(2SR,4RS)-2-exo-(2-Chloro-6-fluorophenyl)-2,3,4,5- tetrahydro-1H-1,4-epoxy-1-benzazepine
Acta Crystallographica Section C (2009) 65, 9 o465-o469
a=9.0768(13)
b=10.9461(9)
c=12.9971(18)
α= 90.00
β= 99.768(9)
γ= 90.00
V = 1272.6(3)
2017280(2SR,4RS)-7-methyl-2-exo-(4-methylphenyl)- 2,3,4,5-tetrahydro-1H-1,4-epoxy-1-benzazepine
Acta Crystallographica Section C (2009) 65, 9 o465-o469
a=9.7687(9)
b=10.3022(17)
c=14.239(2)
α= 90.00
β= 108.222(10)
γ= 90.00
V = 1361.1(3)
2017282C17H16ClNO
Acta Crystallographica Section C (2009) 65, 9 o465-o469
a=8.7150(9)
b=10.406(2)
c=15.312(4)
α= 99.547(19)
β= 90.621(14)
γ= 96.514(13)
V = 1359.9(5)
2017300(E)-3-(4-Methylphenyl)-2-(2-thienyl)acrylonitrile
Acta Crystallographica Section C (2009) 65, 9 o444-o446
a=21.4869(7)
b=7.0302(3)
c=14.1810(5)
α= 90.00
β= 126.173(2)
γ= 90.00
V = 1729.22(12)
20173024,4-(2-thienylmethylene)bis(6-allyl-3-chloro-2-methylaniline)
Acta Crystallographica Section C (2009) 65, 9 o479-o482
a=8.7263(2)
b=10.6766(2)
c=12.2691(3)
α= 77.1100(10)
β= 87.7930(10)
γ= 82.367(2)
V = 1104.35(4)
2017303(2RS,4SR)-2-exo-(5-bromo-2-thienyl)-7-chloro- 2,3,4,5-tetrahydro-1H-1,4-epoxy-1-benzazepine
Acta Crystallographica Section C (2009) 65, 9 o487-o491
a=10.7959(11)
b=14.2116(16)
c=17.4303(11)
α= 90.00
β= 90.00
γ= 90.00
V = 2674.3(4)
2017304(2RS,4SR)-2-exo-(5-methyl-2-thienyl)-2,3,4,5- tetrahydro-1H-1,4-epoxy-1-benzazepine
Acta Crystallographica Section C (2009) 65, 9 o487-o491
a=8.3789(12)
b=9.6964(14)
c=30.952(4)
α= 90.00
β= 90.00
γ= 90.00
V = 2514.7(6)
2017305(2RS,4SR)-7-chloro-2-exo-(5-methyl-2-thienyl)- 2,3,4,5-tetrahydro-1H-1,4-epoxy-1-benzazepine
Acta Crystallographica Section C (2009) 65, 9 o487-o491
a=15.042(3)
b=15.739(3)
c=5.6216(13)
α= 90.00
β= 100.120(16)
γ= 90.00
V = 1310.2(5)
20174076-amino-2-dimethylamino-3-methyl-5-nitrosopyrimidin-4(3H)-one monohydrate
Acta Crystallographica Section C (2009) 65, 11 o549-o552
a=11.8125(6)
b=7.1372(7)
c=11.8588(19)
α= 90.00
β= 107.910(4)
γ= 90.00
V = 951.34(19)
20175777-Amino-5-methyl-2-phenyl-6-(phenyldiazenyl)pyrazolo[1,5-a]pyrimidine
Acta Crystallographica Section C (2010) 66, 3 o133-o136
a=9.6342(13)
b=33.216(5)
c=9.747(3)
α= 90.00
β= 90.237(18)
γ= 90.00
V = 3119.1(11)
2017585(2SR,4RS)-2-exo-vinyl-2,3,4,5-tetrahydro-1H- 1,4-epoxy-1-benzazepine
Acta Crystallographica Section C (2010) 66, 4 o209-o214
a=9.8070(13)
b=7.3982(7)
c=13.738(2)
α= 90.00
β= 105.441(11)
γ= 90.00
V = 960.8(2)
2017586(2SR,4RS)-8-chloro-9-methyl-2-exo-(2-methylprop-1-enyl)- 2,3,4,5-tetrahydro-1H-1,4-epoxy-1-benzazepine
Acta Crystallographica Section C (2010) 66, 4 o209-o214
a=11.0631(7)
b=5.7212(5)
c=21.203(6)
α= 90.00
β= 102.587(16)
γ= 90.00
V = 1309.8(4)
2017587(2SR,4RS)-8-chloro-9-methyl-2-exo-(prop-1-en-2-yl)- 2,3,4,5-tetrahydro-1H-1,4-epoxy-1-benzazepine
Acta Crystallographica Section C (2010) 66, 4 o209-o214
a=8.6828(11)
b=10.1456(6)
c=14.2976(16)
α= 90.000
β= 107.587(9)
γ= 90.000
V = 1200.6(2)
20175953-(4-nitrophenyl)-4-phenyl-1H-pyrazolo[3,4-b]pyridine
Acta Crystallographica Section C (2010) 66, 4 o163-o167
a=7.04080(10)
b=9.6360(3)
c=11.1961(3)
α= 84.9060(10)
β= 89.177(2)
γ= 81.012(2)
V = 747.31(3)
20175992-exo-phenyl-2,3,4,5-tetrahydro-1H-1,4-epoxy-1-benzazepine
Acta Crystallographica Section C (2010) 66, 4 o233-o240
a=10.7475(7)
b=10.7842(12)
c=20.5812(19)
α= 90.00
β= 91.688(7)
γ= 90.00
V = 2384.4(4)
20176002-exo-(4-chlorophenyl)-2,3,4,5-tetrahydro-1H- 1,4-epoxy-1-benzazepine
Acta Crystallographica Section C (2010) 66, 4 o233-o240
a=8.2405(14)
b=11.5432(16)
c=27.442(2)
α= 90.00
β= 101.030(13)
γ= 90.00
V = 2562.1(6)
20176012-exo-(3-methylphenyl)-2,3,4,5-tetrahydro-1H-1,4- epoxy-1-benzazepine
Acta Crystallographica Section C (2010) 66, 4 o233-o240
a=10.9966(17)
b=23.691(10)
c=10.6323(8)
α= 90.00
β= 111.661(8)
γ= 90.00
V = 2574.3(12)
20176032-exo-(4-bromophenyl)-7-chloro-2,3,4,5- tetrahydro-1H-1,4-epoxy-1-benzazepine
Acta Crystallographica Section C (2010) 66, 4 o233-o240
a=15.3626(16)
b=11.5436(13)
c=7.8832(13)
α= 90.00
β= 96.080(11)
γ= 90.00
V = 1390.1(3)
2017635(2SR,4RS)-7-chloro-2-exo-(2-methylprop-1-enyl)- 2,3,4,5-tetrahydro-1H-1,4-epoxy-1-benzazepine
Acta Crystallographica Section C (2010) 66, 4 o209-o214
a=5.6445(5)
b=25.744(3)
c=8.3894(11)
α= 90.00
β= 95.124(9)
γ= 90.00
V = 1214.2(2)
2017636(2RS,4RS)-8-chloro-9-methyl-2-endo-(2-methylprop-1-enyl)- 2,3,4,5-tetrahydro-1H-1,4-epoxy-1-benzazepine
Acta Crystallographica Section C (2010) 66, 4 o209-o214
a=5.2890(9)
b=9.3076(16)
c=13.551(3)
α= 94.554(15)
β= 94.684(15)
γ= 97.298(14)
V = 656.7(2)
20176755-Acetyl-2-chloro-8,11-dimethyl-5,6,11,12- tetrahydrodibenzo[b,f]azocine
Acta Crystallographica Section C (2010) 66, 6 o284-o288
a=8.3396(3)
b=21.7131(7)
c=9.2010(3)
α= 90.00
β= 106.683(2)
γ= 90.00
V = 1595.97(9)
201767614-acetyl-8,11-dimethyl-7,8,13,14- tetrahydrobenzo[f]naphtho[1,2-b]azocine—–14-acetyl- 8,9-dimethyl-7,8,13,14-tetrahydrobenzo[f]naphtho[1,2-b]azocine (74/26)
Acta Crystallographica Section C (2010) 66, 6 o284-o288
a=18.9549(10)
b=9.8917(4)
c=9.4354(5)
α= 90.00
β= 97.348(3)
γ= 90.00
V = 1754.57(15)
20177622-methoxy-4-(pyrrolo[1,2-a]quinoxalin-4-yl)phenol
Acta Crystallographica Section C (2010) 66, 8 o385-o388
a=7.9278(8)
b=15.2929(18)
c=22.410(4)
α= 90.00
β= 90.326(12)
γ= 90.00
V = 2716.9(6)
20177632-methoxy-4-(pyrrolo[1,2-a]quinoxalin-4-yl)phenol
Acta Crystallographica Section C (2010) 66, 8 o385-o388
a=7.9278(8)
b=15.2929(18)
c=22.410(4)
α= 90.00
β= 90.326(12)
γ= 90.00
V = 2716.9(6)
2017764(9E)-9-benzylidene-3-methyl-2-(methylthio)-5-phenyl- 5,6,7,8,9,10-hexahydropyrimido[4,5-b]quinolin- 4(3H)-one
Acta Crystallographica Section C (2010) 66, 8 o389-o391
a=8.382(2)
b=10.777(3)
c=12.745(4)
α= 73.18(3)
β= 85.13(4)
γ= 76.43(3)
V = 1071.1(6)
2017837(2S*,4R*)-2-exo-(1-Naphthyl)-2,3,4,5-tetrahydro- 1H-1,4-epoxy-1-benzazepine
Acta Crystallographica Section C (2010) 66, 11 o540-o546
a=8.974(4)
b=7.1817(8)
c=22.718(9)
α= 90.00
β= 95.39(3)
γ= 90.00
V = 1457.7(9)
2017838(2SR,4RS)-7-Methyl-2-exo-(1-naphthyl)-2,3,4,5-tetrahydro- 1H-1,4-epoxy-1-benzazepine
Acta Crystallographica Section C (2010) 66, 11 o540-o546
a=10.7760(13)
b=8.9612(11)
c=15.4241(15)
α= 90.00
β= 96.799(10)
γ= 90.00
V = 1479.0(3)
201784310-Benzyl-4-oxo-2,3,4,10-tetrahydropyrimido[4,5-b]quinolin-2-iminium chloride sesquihydrate
Acta Crystallographica Section C (2010) 66, 9 o469-o472
a=18.8725(10)
b=18.4777(8)
c=13.417(2)
α= 90.00
β= 134.307(7)
γ= 90.00
V = 3348.2(7)
20179423-Benzyl-2-(4-fluorophenyl)-1,3-thiazolidin-4-one
Acta Crystallographica Section C (2011) 67, 1 o10-o12
a=9.6931(9)
b=16.8888(16)
c=16.4202(18)
α= 90.00
β= 94.706(12)
γ= 90.00
V = 2679.0(5)
2017947Methyl 4-[(1-acetyl-3-tert-butyl-1H-pyrazol-5-yl)amino]-3-nitrobenzoate
Acta Crystallographica Section C (2011) 67, 1 o26-o28
a=11.9079(15)
b=15.6452(13)
c=9.2550(10)
α= 90.00
β= 91.727(11)
γ= 90.00
V = 1723.4(3)
20179801,4-Phenylenebis(methylene) bis(9H-carbazole-9-carbodithioate)
Acta Crystallographica Section C (2011) 67, 2 o77-o79
a=10.296(2)
b=10.0793(19)
c=13.137(2)
α= 90.00
β= 96.646(14)
γ= 90.00
V = 1354.2(4)
20183646-Chloro-3-methyl-4-(4-nitrophenyl)-1- phenylpyrazolo[3,4-b]pyridine-5-carbaldehyde
Acta Crystallographica Section C (2012) 68, 1 o12-o18
a=11.7839(13)
b=9.9890(4)
c=15.71(2)
α= 90.00
β= 106.084(8)
γ= 90.00
V = 1777(2)
20184247-bromo-2-exo-(2-chlorophenyl)-2,3,4,5-tetrahydro- 1,4-epoxynaphtho[1,2-b]azepine
Acta Crystallographica Section C (2012) 68, 3 o123-o125
a=11.5083(8)
b=8.1027(6)
c=18.3210(16)
α= 90.00
β= 110.505(5)
γ= 90.00
V = 1600.2(2)
20184282-exo-(5-nitrofuran-2-yl)-2,3,4,5-tetrahydro-1,4-epoxy- 1H-1-benzazepine
Acta Crystallographica Section C (2012) 68, 3 o131-o140
a=7.2248(5)
b=18.1447(19)
c=9.4504(8)
α= 90.00
β= 94.279(6)
γ= 90.00
V = 1235.42(19)
20184297-fluoro-2-exo-(1-methyl-1H-pyrrol-2-yl)-2,3,4,5-tetrahydro- 1,4-epoxy-1H-1-benzazepine
Acta Crystallographica Section C (2012) 68, 3 o131-o140
a=27.141(4)
b=5.4082(7)
c=17.2849(18)
α= 90.00
β= 103.275(9)
γ= 90.00
V = 2469.4(6)
20184307-fluoro-2-exo-(5-methylfuran-2-yl)-2,3,4,5-tetrahydro-1,4-epoxy- 1H-1-benzazepine
Acta Crystallographica Section C (2012) 68, 3 o131-o140
a=5.5265(5)
b=10.6652(19)
c=20.905(4)
α= 90.00
β= 97.166(11)
γ= 90.00
V = 1222.5(3)
20184317-fluoro-2-exo-(3-methylthiophen-2-yl)-2,3,4,5-tetrahydro-1,4-epoxy- 1H-1-benzazepine
Acta Crystallographica Section C (2012) 68, 3 o131-o140
a=9.272(2)
b=10.9142(13)
c=12.963(2)
α= 90.00
β= 101.023(11)
γ= 90.00
V = 1287.6(4)
20184327-fluoro-2-exo-(5-methylthiophen-2-yl)-2,3,4,5-tetrahydro-1,4-epoxy- 1H-1-benzazepine
Acta Crystallographica Section C (2012) 68, 3 o131-o140
a=9.2106(16)
b=10.906(2)
c=13.4259(13)
α= 90.00
β= 106.086(12)
γ= 90.00
V = 1295.8(4)